Analyst Ratings February 23, 2026

UBS Sticks With Buy on Target Ahead of Q4 Results, Sees Clear Path to Improvement

Analyst maintains $130 price target, citing calibrated expectations and management's reiterated guidance as reasons for limited downside risk

By Sofia Navarro TGT
UBS Sticks With Buy on Target Ahead of Q4 Results, Sees Clear Path to Improvement
TGT

UBS reiterated a Buy rating on Target Corp. and kept a $130.00 price target ahead of the retailer's fourth-quarter earnings report. The firm said consensus expectations appear properly set for the quarter, noted Target has reaffirmed its 2025 guidance, and expects management to present realistic, achievable guidance and a credible plan for 2026 improvement. UBS' price target is derived from a roughly 15 times P/E multiple on its calendar year 2027 EPS estimate of $8.75. Market metrics cited in recent analysis include Target's current P/E of 13.74 and a reported fair value of $118.19.

Key Points

  • UBS reaffirmed a Buy rating on Target and maintained a $130.00 price target ahead of Q4 results.
  • UBS views market expectations as properly calibrated for Q4, with the buyside benchmark for comparable sales near -2% to -3%.
  • Price target is based on roughly a 15 times P/E multiple on UBS' CY2027 EPS estimate of $8.75; current P/E is 13.74 and an analysis cites a fair value of $118.19.

UBS has reiterated its Buy rating on Target Corp. (TGT) and maintained a $130.00 price target as investors await the retailer's fourth-quarter earnings. The firm told clients that a number of factors make the stock's near-term setup constructive ahead of the results.

According to UBS, market expectations for comparable sales in the fourth quarter appear well calibrated. Conversations with institutional investors suggest the buyside benchmark for comparable sales is roughly negative 2% to negative 3%, a level UBS views as consistent with current sentiment heading into the quarterly print.

UBS noted that Target has already reaffirmed its 2025 guidance, which the firm believes reduces the likelihood of major surprises in the upcoming report. The broker added that it expects the company to present a credible plan that will help investors believe Target is positioned to show improvement in 2026.

On guidance, UBS emphasized that management should set realistic, achievable targets for the year ahead. Specifically, the firm said the mid-point of the company's earnings per share outlook should be at least around $8.00. That level of conservatism, UBS argued, would keep expectations attainable and support investor confidence.

UBS derived its $130.00 price target by applying an approximate 15 times price-to-earnings multiple to its calendar year 2027 earnings per share estimate of $8.75. As a point of comparison, Target is currently trading at a P/E ratio of 13.74.

Separately, an equity analysis referenced in recent market commentary places a fair value for the stock at $118.19 and notes the company is "Trading at a low earnings multiple." That valuation suggests upside remains even before reaching UBS's $130.00 target.

Investors should also note the timing of the next earnings release, which is scheduled for March 10. Ahead of that date, analysts and clients will be watching for the detail and tone of any updated guidance as well as commentary on the path to margin and sales recovery.


In concurrent corporate developments, Target has announced several executive leadership changes as part of a strategic effort to accelerate growth under its new chief executive officer.

Michael J. Fiddelke has been named Chief Executive Officer and appointed to the company's board, with an annual base salary of $1.3 million. Fiddelke is also eligible for a cash incentive under the company's Short-Term Incentive Plan and for stock-based awards under the 2020 Long-Term Incentive Plan.

Effective February 15, Lisa Roath will assume the role of Executive Vice President and Chief Operating Officer, with an annual base salary of $775,000. In the company's merchandising ranks, Cara Sylvester will shift roles from Chief Guest Experience Officer to Chief Merchandising Officer.

Target also announced additions to its board of directors: John R. Hoke III and Stephen B. Bratspies have been named directors. Hoke will serve on the Governance & Sustainability and Compensation & Human Capital Management committees.

These leadership moves are presented by Target as part of a broader effort to align executive roles and the board with the company's evolving strategic priorities and to support the growth agenda under CEO Fiddelke.


Investors and market participants will be assessing both the upcoming quarterly results and the implications of the management changes. UBS' view that the near-term setup is favorable rests on calibrated market expectations, reaffirmed guidance, and the potential for management to present a credible plan for future improvement.

Risks

  • Comparable sales could deviate from the roughly -2% to -3% buyside expectation, which would affect near-term stock performance - impacts retail and consumer discretionary sectors.
  • If management's guidance or the credibility of its plan for 2026 improvement falls short of investor expectations, the stock could face pressure - impacts equity markets and investor sentiment in retail names.
  • Leadership transitions carry execution risk as new executives and board members assume responsibilities; missteps could affect operational performance and strategic execution - impacts corporate governance and retail operations.

More from Analyst Ratings

Raymond James Upholds Outperform on Tidewater After $500M Brazilian Fleet Purchase Feb 23, 2026 Morgan Stanley Sticks With Overweight on Gilead After Arcellx Acquisition Feb 23, 2026 Truist Sticks With Buy on Axsome, Cites Sales Push Ahead of April FDA Decision Feb 23, 2026 TD Cowen Lifts Axsome Price Target to $215 Citing Continued Auvelity Momentum Feb 23, 2026 Mizuho Sticks With Outperform on PayPal as Takeover Interest Surfaces Feb 23, 2026